Allurion Technologies (ALUR) Competitors $0.35 +0.07 (+24.33%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ALUR vs. NSPR, VANI, HYPR, APYX, MLSS, OM, APT, MODD, CTSO, and NXLShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include InspireMD (NSPR), Vivani Medical (VANI), Hyperfine (HYPR), Apyx Medical (APYX), Milestone Scientific (MLSS), Outset Medical (OM), Alpha Pro Tech (APT), Modular Medical (MODD), Cytosorbents (CTSO), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. InspireMD Vivani Medical Hyperfine Apyx Medical Milestone Scientific Outset Medical Alpha Pro Tech Modular Medical Cytosorbents Nexalin Technology Allurion Technologies (NYSE:ALUR) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Does the media favor ALUR or NSPR? In the previous week, InspireMD had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 1 mentions for InspireMD and 0 mentions for Allurion Technologies. InspireMD's average media sentiment score of 0.59 beat Allurion Technologies' score of 0.00 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment Allurion Technologies Neutral InspireMD Positive Which has more volatility and risk, ALUR or NSPR? Allurion Technologies has a beta of -0.56, suggesting that its stock price is 156% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Is ALUR or NSPR more profitable? Allurion Technologies has a net margin of -71.24% compared to InspireMD's net margin of -413.96%. Allurion Technologies' return on equity of 0.00% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets Allurion Technologies-71.24% N/A -56.75% InspireMD -413.96%-69.42%-57.68% Does the MarketBeat Community prefer ALUR or NSPR? Allurion Technologies received 3 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 87.50% of users gave Allurion Technologies an outperform vote while only 4.88% of users gave InspireMD an outperform vote. CompanyUnderperformOutperformAllurion TechnologiesOutperform Votes787.50% Underperform Votes112.50%InspireMDOutperform Votes44.88%Underperform Votes7895.12% Which has higher earnings and valuation, ALUR or NSPR? InspireMD has lower revenue, but higher earnings than Allurion Technologies. InspireMD is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$34.75M0.65-$80.61M-$0.48-0.73InspireMD$6.82M11.47-$19.92M-$0.75-4.00 Do insiders & institutionals have more ownership in ALUR or NSPR? 21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 22.4% of Allurion Technologies shares are owned by insiders. Comparatively, 29.7% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate ALUR or NSPR? Allurion Technologies presently has a consensus price target of $2.88, indicating a potential upside of 726.15%. InspireMD has a consensus price target of $4.75, indicating a potential upside of 58.33%. Given Allurion Technologies' higher possible upside, equities analysts clearly believe Allurion Technologies is more favorable than InspireMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAllurion Technologies beats InspireMD on 11 of the 18 factors compared between the two stocks. Ad Weiss RatingsNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$22.55M$4.33B$5.12B$19.18BDividend YieldN/A41.46%4.91%3.59%P/E Ratio-0.7225.3791.3441.28Price / Sales0.6545.671,116.6317.59Price / CashN/A43.4642.5821.28Price / Book-0.247.364.795.32Net Income-$80.61M$13.64M$120.07M$989.88M7 Day Performance0.69%-2.81%-1.90%-3.56%1 Month Performance-31.92%0.55%11.43%-3.70%1 Year Performance-90.20%41.80%30.59%12.12% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.0467 of 5 stars$0.35+24.3%$2.88+726.1%-89.7%$22.55M$34.75M-0.72501Gap UpNSPRInspireMD2.1978 of 5 stars$3.00+1.7%$4.75+58.3%+45.6%$78.25M$6.82M-3.9350Analyst ForecastGap UpVANIVivani Medical2.7967 of 5 stars$1.32+0.4%$3.00+128.1%+34.6%$77.89MN/A-2.9120News CoveragePositive NewsHYPRHyperfine2.283 of 5 stars$0.95-4.7%$1.60+67.9%-15.7%$69.52M$13.26M-1.75190APYXApyx Medical1.6647 of 5 stars$1.77+5.4%N/A-37.2%$66.63M$48.54M-2.23270Positive NewsMLSSMilestone Scientific1.4761 of 5 stars$0.83+2.6%$1.25+50.4%+54.0%$64.73M$8.88M-11.5730Analyst ForecastNews CoverageOMOutset Medical2.5559 of 5 stars$1.10-1.4%$4.50+311.0%-79.0%$57.53M$130.38M0.00520Positive NewsGap UpAPTAlpha Pro TechN/A$5.15-1.9%N/A+3.1%$56.65M$59.29M14.19120MODDModular Medical3.1757 of 5 stars$1.53-3.8%$5.00+226.8%-14.7%$53.08MN/A-2.5239News CoverageCTSOCytosorbents2.5619 of 5 stars$0.95-5.9%$2.00+110.5%-50.3%$51.96M$33.79M-2.81186Analyst ForecastPositive NewsGap DownNXLNexalin Technology1.3024 of 5 stars$3.90-1.5%$3.00-23.1%+806.9%$50.16M$162,078.00-6.193Gap Down Related Companies and Tools Related Companies InspireMD Competitors Vivani Medical Competitors Hyperfine Competitors Apyx Medical Competitors Milestone Scientific Competitors Outset Medical Competitors Alpha Pro Tech Competitors Modular Medical Competitors Cytosorbents Competitors Nexalin Technology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ALUR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALUR Stock Alerts